Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Neurology and Therapy|May 23, 2015
Laquinimod therapy in multiple sclerosis: a comprehensive reviewChanna Kolb-Sobieraj, Sahil Gupta, Bianca Weinstock-Guttman
CNS Drugs|March 7, 2018
An Update on the Use of Disease-Modifying Therapy in Pregnant Patients with Multiple SclerosisCaila Vaughn, Aisha Bushra, Channa Kolb, et al.
Cold Spring Harbor Perspectives in Medicine|January 10, 2018
Interferon β for Multiple SclerosisDejan Jakimovski, Channa Kolb, Murali Ramanathan, et al.
Expert Opinion on Biological Therapy|June 30, 2017
Ocrelizumab: a B-cell depleting therapy for multiple sclerosisDejan Jakimovski, Bianca Weinstock-Guttman, Murali Ramanathan, et al.
Expert Opinion on Biological Therapy|July 15, 2016
Use of natalizumab in multiple sclerosis: current perspectivesSirin Gandhi, Dejan Jakimovski, Rahil Ahmed, et al.
Neuropharmacology|December 4, 2017
Fingolimod anti-inflammatory and neuroprotective effects modulation of RAGE axis in multiple sclerosis patientsZohara Sternberg, Channa Kolb, Kailash Chadha, et al.
Multiple Sclerosis and Related Disorders|September 17, 2019
Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosisRobert Zivadinov, Murali Ramanathan, Jesper Hagemeier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 20, 2018
Dalfampridine benefits ambulation but not cognition in multiple sclerosisNikhil Satchidanand, Allison Drake, A Smerbeck, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 29, 2022
Elevated spermidine serum levels in mild cognitive impairment, a potential biomarker of progression to Alzheimer dementia, a pilot studyZohara Sternberg, Rebecca Podolsky, Adam Nir, et al.
Pageof 3